Upgrade to SI Premium - Free Trial

Tonix Pharmaceuticals (TNXP) Reports Q2 Loss of $0.50/Share

August 8, 2016 7:20 AM

Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q2 EPS of ($0.50), versus ($0.73) reported last year.

For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.

Categories

Earnings

Next Articles